Related Experiment Video
Updated: Jul 11, 2026

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity.
Khosrow Rezvani1, Yanfen Teng, David Shim
1Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA.
Nicotine exposure reduces proteasome activity, leading to protein buildup and altered synaptic protein levels. This suggests the ubiquitin-proteasome system (UPS) plays a role in nicotine-induced synaptic plasticity.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The ubiquitin-proteasome system (UPS) is crucial for protein regulation, impacting synaptic transmission and plasticity.
- Nicotine affects synaptic function through incompletely understood mechanisms.
Purpose of the Study:
- To investigate the impact of nicotine on the UPS at mammalian synapses.
- To explore the role of the UPS in nicotine-dependent synaptic plasticity.
Main Methods:
- Assessing proteasomal activity and ubiquitinated protein levels after nicotine exposure.
- Quantifying levels of key synaptic proteins (nAChR, AMPA, NMDA, Homer-1A, PSD-95, Shank) via Western blotting.
- Investigating the interaction between nicotine and the 20S proteasome using competition binding assays.
Main Results:
- Nicotine reduced proteasomal activity and increased ubiquitinated synaptic proteins.
- Nicotine exposure altered levels of synaptic receptors and plasticity-related proteins, including decreased degradation of the alpha7 nicotinic acetylcholine receptor (nAChR) subunit.
- Nicotine directly interacted with the 20S proteasome, and nAChR antagonism only partially blocked its effects on proteasomal activity.
Conclusions:
- Nicotine inhibits proteasomal activity, leading to altered synaptic protein homeostasis.
- The UPS is implicated in mediating nicotine's effects on synaptic plasticity.
- Nicotine may directly interact with the proteasome, suggesting a novel mechanism of action beyond nAChR activation.
More Related Videos
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drugs Affecting Neurotransmitter Release or Uptake
CNS Depressants: Alcohol and Nicotine
Drugs Affecting Neurotransmitter Synthesis
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

